Because they are peptides, and peptides are fragile biologics rather than simple small molecules
To our knowledge, this study represents the largest cohort to date investigating the association between GLP-1 RAs and cardiovascular and kidney outcomes in KTRs with T2DM
If you are not 100% sure of your vials concentration or syringe type, confirm with the dispensing pharmacy or your prescribing clinician before injecting
[1] [3] According to the UK SmPC, dosing starts at 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks until the target dose (5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) is reached, based on individual response and tolerability
Many of us rely on a morning cup of coffee or a jolt of caffeine in the afternoon to help us get through the day
Published studies consistently show GLP-1 receptor agonists slow gastric emptying and influence intestinal movement